Results
1 -
10 of
207 Xiong Zhu, Yue Wang and Tao Lu .
2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid pyridine solvate , Acta Cryst (2009). E65, o2603Â Â Pike Andy, Storer R. Ian, Owen Robert M., Armstrong Emma, Benn Caroline L., Bictash Magda, Cheung Kathy F. K., Costelloe Kathryn, Dardennes Emmanuel, Impey Emma, Milliken Philip H., Mortimer-Cassen Elisabeth, Pearce Hannah J..
The design, synthesis and evaluation of low molecular weight acidic sulfonamides as URAT1 inhibitors for the treatment of gout, Med. Chem. Commun., 2016 Storer R. Ian, Owen Robert M., Pike Andy, Benn Caroline L., Armstrong Emma, Blakemore David C., Bictash Magda, Costelloe Kathryn, Impey Emma, Milliken Philip H., Mortimer-Cassen Elisabeth, Pearce Hannah J., Pibworth Benjamin, Toschi Gianna.
The discovery and evaluation of diaryl ether heterocyclic sulfonamides as URAT1 inhibitors for the treatment of gout, Med. Chem. Commun., 2016 Potential Xanthine Oxidase Inhibitory Activity of Endophytic Lasiodiplodia pseudotheobromae, Applied Biochemistry and Biotechnology Zonal Distribution of Allopurinol-Oxidizing Enzymes in Rat Liver, Purine and Pyrimidine Metabolism in Man IX Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics, Arthritis Research & Therapy Febuxostat, ein neues Pharmakon zur Behandlung der Gicht, Der Kardiologe Acute kidney injury observed during phase 1 clinical trials of a novel xanthine oxidase/URAT1 dual inhibitor PF-06743649, Clinical Rheumatology